{"title":"用于生产生物技术/生物制品的细胞底物的衍生和表征的ICH指南和PhEur专著。国际协调会议。","authors":"R Dobbelaer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This presentation gives an overview of the guidance which is available in the EU as it would be applicable to licensing requirements for influenza vaccines produced on banked cells. Whereas ensuring compliance of cell banks would be relatively straightforward, ensuring compliance of new virus seeds (and possibly harvests) with requirements concerning adventitious viral contamination needs further evaluation.</p>","PeriodicalId":11308,"journal":{"name":"Developments in biological standardization","volume":"98 ","pages":"159-65; discussion 167"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ICH guidelines and PhEur monographs on derivation and characterisation of cell substrates used for production of biotechnological/biological products. International Conference on Harmonisation.\",\"authors\":\"R Dobbelaer\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This presentation gives an overview of the guidance which is available in the EU as it would be applicable to licensing requirements for influenza vaccines produced on banked cells. Whereas ensuring compliance of cell banks would be relatively straightforward, ensuring compliance of new virus seeds (and possibly harvests) with requirements concerning adventitious viral contamination needs further evaluation.</p>\",\"PeriodicalId\":11308,\"journal\":{\"name\":\"Developments in biological standardization\",\"volume\":\"98 \",\"pages\":\"159-65; discussion 167\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Developments in biological standardization\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developments in biological standardization","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ICH guidelines and PhEur monographs on derivation and characterisation of cell substrates used for production of biotechnological/biological products. International Conference on Harmonisation.
This presentation gives an overview of the guidance which is available in the EU as it would be applicable to licensing requirements for influenza vaccines produced on banked cells. Whereas ensuring compliance of cell banks would be relatively straightforward, ensuring compliance of new virus seeds (and possibly harvests) with requirements concerning adventitious viral contamination needs further evaluation.